Piper Sandler is sticking to its S&P 500 (SP500) year-end target of 6,600 points, despite the recent dip in the benchmark ...

Fintel reports that on March 21, 2025, Piper Sandler downgraded their outlook for TELA Bio (NasdaqGM:TELA) from Overweight to ...

In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Skye Bioscience (SKYE – Research Report), with a ...

Piper Sandler analyst Paul Newsome maintained a Buy rating on Allstate (ALL – Research Report) today and set a price target of $248.00. The ...

Fintel reports that on March 20, 2025, Piper Sandler downgraded their outlook for Stellantis N.V. (NYSE:STLA) from Overweight ...

Tela Bio (TELA) stock drops as Q4 2024 and 2025 outlook miss expectations, prompting Piper Sandler to downgrade it shares. Read more here.

Piper Sandler Companies had a return on equity of 17.00% and a net margin of 11.87%. During the same quarter last year, the business posted $4.03 earnings per share.

Piper Sandler demonstrated resilience in its financial performance for the fourth quarter of 2024, reporting adjusted earnings per share (EPS) of $4.80, surpassing both JMP Securities’ estimate ...

Proficio Capital Partners LLC acquired a new position in Piper Sandler Companies (NYSE:PIPR – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...